Investing.com - Takeda Pharma ADR reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Takeda Pharma ADR announced earnings per share of $0.25 on revenue of $7.63B. Analysts polled by Investing.com anticipated EPS of $0.06 on revenue of $7.29B.
Takeda Pharma ADR shares are up 30.31% from the beginning of the year , still down 12.61% from its 52 week high of $20.93 set on November 19, 2019. They are outperforming the Nikkei 225 which is down 8.23% from the start of the year.
Takeda Pharma ADR shares gained 0.72% in intra-day trade following the report.
Takeda Pharma ADR follows other major sector earnings this month
Takeda Pharma ADR's report follows an earnings missed by Iberdrola SA on July 22, who reported EPS of $0.42 on revenue of $8.16B, compared to forecasts EPS of $0.46 on revenue of $9.73B.
KDDI Corp PK had beat expectations on Friday with second quarter EPS of $0.38 on revenue of $11.83B, compared to forecast for EPS of $0.33 on revenue of $11.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar